Literature DB >> 26300162

Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.

Lin Liu1, Yijin Song2, Ming Zhao1, Zhuwen Yi3, Qiyi Zeng4.   

Abstract

PURPOSE: Acute kidney injury (AKI) is a frequent complication of sepsis. The present work examined the therapeutic potential of edaravone (EDA), a free radical scavenger, for inhibiting sepsis-induced renal injury.
METHODS: Saline and lipopolysaccharide (LPS) were injected intraperitoneally at a dose of 10 mg/kg of body weight. EDA, 3-methyl-1-phenyl-pyrazolin-5-one, was administrated intravenously at a dose of 3 mg/kg of body weight to male Wistar rats. Wistar rats were divided into four groups: treatment with LPS alone, treatment with LPS followed by EDA administration, treatment with saline followed by EDA administration, and untreated controls.
RESULTS: Administration of LPS caused a significant increase in BUN and serum creatinine levels with concurrent pathological alterations in kidney tissues. EDA treatment relieved all these changes. Moreover, EDA reduced LPS-induced elevation of serum TNF-α and IL-6 in rats. Furthermore, EDA could prevent mitochondrial membrane potential loss induced by LPS and reverse the changes in mitochondrial antioxidant (such as T-AOC, SOD, CAT, and GSH) and mitochondrial MDA levels. TUNEL staining of the kidney sections and immunoblot analysis on renal cortical lysates showed that EDA treatment resulted in reduced number of apoptotic cells, which occurred concomitantly with decreased levels of cytochrome c and cleaved caspase 3. Following LPS treatment of rat renal tubular cells, mitochondrial fragmentation was observed prior to apoptosis, which was inhibited by EDA.
CONCLUSIONS: EDA prevents LPS-induced AKI not only by reducing the production of inflammatory cytokines, but also by attenuating oxidative damage in renal mitochondria, mitochondrial fragmentation, and apoptosis of renal cells.

Entities:  

Keywords:  Acute kidney injury; Edaravone; LPS; Mitochondrial fragmentation; Sepsis

Mesh:

Substances:

Year:  2015        PMID: 26300162     DOI: 10.1007/s11255-015-1070-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Role of peroxynitrite in sepsis-induced acute kidney injury in an experimental model of sepsis in rats.

Authors:  Mariana Seija; Cecilia Baccino; Nicolás Nin; Carolina Sánchez-Rodríguez; Rosario Granados; Antonio Ferruelo; Leticia Martínez-Caro; Jesús Ruíz-Cabello; Marta de Paula; Oscar Noboa; Andrés Esteban; José Angel Lorente
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

Review 2.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 3.  Isolation and subfractionation of mitochondria from animal cells and tissue culture lines.

Authors:  Francesco Pallotti; Giorgio Lenaz
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

Review 4.  Mitochondrial dynamics: to be in good shape to survive.

Authors:  Sébastien Herzig; Jean-Claude Martinou
Journal:  Curr Mol Med       Date:  2008-03       Impact factor: 2.222

5.  Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.

Authors:  Masahiro Kamouchi; Hironori Sakai; Yutaka Kiyohara; Kazuo Minematsu; Kunihiko Hayashi; Takanari Kitazono
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-06-22       Impact factor: 2.136

6.  Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.

Authors:  Yuko Takayasu; Junko Nakaki; Toshiyuki Kawasaki; Ken Koda; Yukio Ago; Akemichi Baba; Toshio Matsuda
Journal:  J Pharmacol Sci       Date:  2007-04-04       Impact factor: 3.337

7.  A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo.

Authors:  Minoru Satoh; Naoki Kashihara; Sohachi Fujimoto; Hideyuki Horike; Takehiko Tokura; Tamehachi Namikoshi; Tamaki Sasaki; Hirofumi Makino
Journal:  J Pharmacol Exp Ther       Date:  2003-03-20       Impact factor: 4.030

8.  Effects of ghrelin on sepsis-induced acute kidney injury: one step forward.

Authors:  Akef Khowailed; Sandra Mourad Younan; Hend Ashour; Abd Elkarim Kamel; Nivin Sharawy
Journal:  Clin Exp Nephrol       Date:  2014-07-08       Impact factor: 2.801

9.  Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression.

Authors:  Katare Gopalrao Rajesh; Shiro Sasaguri; Ryoko Suzuki; Hironori Maeda
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-19       Impact factor: 4.733

10.  Chromium-induced nephrotoxicity and ameliorative effect of carvedilol in rats: Involvement of oxidative stress, apoptosis and inflammation.

Authors:  Bidya Dhar Sahu; Meghana Koneru; Shriharsh R Bijargi; Anudeep Kota; Ramakrishna Sistla
Journal:  Chem Biol Interact       Date:  2014-09-22       Impact factor: 5.192

View more
  7 in total

Review 1.  Kidney disease models: tools to identify mechanisms and potential therapeutic targets.

Authors:  Yin-Wu Bao; Yuan Yuan; Jiang-Hua Chen; Wei-Qiang Lin
Journal:  Zool Res       Date:  2018-03-18

2.  Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice.

Authors:  Dalong Ni; Dawei Jiang; Christopher J Kutyreff; Jianhao Lai; Yongjun Yan; Todd E Barnhart; Bo Yu; Hyung-Jun Im; Lei Kang; Steve Y Cho; Zhaofei Liu; Peng Huang; Jonathan W Engle; Weibo Cai
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

3.  Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury.

Authors:  Dong-Yang Zhang; Tianhui Tu; Muhammad Rizwan Younis; Kathy S Zhu; Hengke Liu; Shan Lei; Junle Qu; Jing Lin; Peng Huang
Journal:  Theranostics       Date:  2021-10-17       Impact factor: 11.556

Review 4.  Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection.

Authors:  Sun Joo Cha; Kiyoung Kim
Journal:  Antioxidants (Basel)       Date:  2022-01-20

5.  Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study.

Authors:  Hui-Qin Yang; Wen-Jun Yin; Kun Liu; Man-Cang Liu; Xiao-Cong Zuo
Journal:  BMJ Open       Date:  2022-04-19       Impact factor: 3.006

6.  Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway.

Authors:  Chao He; Wei Zhang; Suobei Li; Wei Ruan; Junmei Xu; Feng Xiao
Journal:  Oxid Med Cell Longev       Date:  2018-03-22       Impact factor: 6.543

7.  Protection of procyanidin B2 on mitochondrial dynamics in sepsis associated acute kidney injury via promoting Nrf2 nuclear translocation.

Authors:  Jian-Xing Liu; Chen Yang; Ze-Jian Liu; Hong-Yong Su; Wei-Huang Zhang; Qingjun Pan; Hua-Feng Liu
Journal:  Aging (Albany NY)       Date:  2020-08-15       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.